US Patent 8124582 Treatment of diabetes
Patent 8124582 was granted and assigned to Fibrogen, Inc. on February, 2012 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8124582 Treatment of diabetes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
